T2 relaxometry in high-grade gliomas: Preliminary analysis of peritumoral tissue characteristics

Abstract

Background

This study aims to assess whether T2 relaxometry can distinguish tissue characteristics between high-grade gliomas and non-infiltrative lesions.

Methods

We report our initial experience using the Relaxo LNI software to analyze multi-echo T2 relaxometry magnetic resonance imaging in patients with high-grade gliomas. For comparison, peritumoral T2-hyperintense areas in meningiomas and metastases were used as reference regions for vasogenic edema, based on the established concept that these tumor types typically do not infiltrate adjacent tissue. In contrast, peritumoral hyperintensity observed in high-grade gliomas may represent either vasogenic edema or tumor infiltration.

Results

Data from 30 patients were analyzed, including 20 with high-grade gliomas and 10 with metastasis or meningiomas. A statistically significant difference was observed in multi-echo T2 relaxation values between the glioma and non-glioma groups (p < 0.05). Mean T2 relaxation times were longer in the high-grade glioma group than in the non-glioma group (p < 0.05). Within the high-grade glioma group, central regions showed significantly longer mean relaxation times than peripheral regions (p < 0.05).

Conclusion

Our preliminary findings suggest that T2 relaxometry identifies differences in relaxation profiles between tumor tissue and control edema, indicating potential value in detecting variations in peritumoral tissue composition in high-grade gliomas. However, these results are exploratory and hypothesis-generating, lack histopathological validation, and require further investigation to clarify the role of T2 mapping in preoperative planning.

Keywords

high-grade glioma glioblastoma edema T2 relaxometry magnetic resonance imaging

Get full access to this article

View all access options for this article.

References

Artzi

Bokstein

Blumenthal

, et al. Differentiation between vasogenic-edema versus tumor-infiltrative area in patients with glioblastoma during bevacizumab therapy: a longitudinal MRI study. Eur J Radiol 2014; 83(7): 1250–1256. https://doi.org/10.1016/j.ejrad.2014.03.026

Pavlisa

Rados

Pavlisa

, et al. The differences of water diffusion between brain tissue infiltrated by tumor and peritumoral vasogenic edema. Clin Imag 2009; 33(2): 96–101. https://doi.org/10.1016/j.clinimag.2008.06.035

Kinoshita

Goto

Okita

, et al. Diffusion tensor-based tumor infiltration index cannot discriminate vasogenic edema from tumor-infiltrated edema. J Neuro Oncol 2010; 96(3): 409–415. https://doi.org/10.1007/s11060-009-9979-0

Gihr

Horvath-Rizea

Kohlhof-Meinecke

, et al. Diffusion weighted imaging in gliomas: a histogram-based approach for tumor characterization. Cancers 2022; 14(14): 3393. https://doi.org/10.3390/cancers14143393

Lê

Delingette

Kalpathy-cramer

, et al.Multimodal Analysis of Vasogenic Edema in Glioblastoma Patients for Radiotherapy Planning. Workshop Image-Guided Adaptive Radiation Therapy, Sep 2014, Boston, United States. ⟨hal-01093397⟩. https://doi.org/10.54294/i2w39x

Ellingson

Cloughesy

Lai

, et al. Quantification of edema reduction using differential quantitative T2 (DQT2) relaxometry mapping in recurrent glioblastoma treated with bevacizumab. J Neuro Oncol 2012; 106(1): 111–119. https://doi.org/10.1007/s11060-011-0638-x

Giacomini

De Souza

JPSA

Formentin

, et al. Temporal lobe structural evaluation after transsylvian selective amygdalohippocampectomy. Neurosurg Focus 2020; 48(4): E14. https://doi.org/10.3171/2020.1.FOCUS19937

Molinaro

Hervey-Jumper

Morshed

, et al. Association of maximal extent of resection of contrast-enhanced and Non–contrast-enhanced tumor with survival within molecular subgroups of patients with newly diagnosed glioblastoma. JAMA Oncol 2020; 6(4): 495–503. https://doi.org/10.1001/jamaoncol.2019.6143

Nabors

Hattangadi-Gluth

Horbinski

, et al. NCCN CNS tumor guidelines update for 2024. Neuro Oncol 2025; 27(3): 595–596. https://doi.org/10.1093/neuonc/noae267

10.

Amjad

Zeinali Zadeh

Azmoudeh-Ardalan

, et al. Evaluation of multimodal MR imaging for differentiating infiltrative versus reactive edema in brain gliomas. Br J Neurosurg 2023; 37(5): 1031–1039. https://doi.org/10.1080/02688697.2020.1849541

11.

Min

Niu

Rana

, et al. Differentiation of pure vasogenic edema and tumor-infiltrated edema in patients with peritumoral edema by analyzing the relationship of axial and radial diffusivities on 3.0T MRI. Clin Neurol Neurosurg 2013; 115(8): 1366–1370. https://doi.org/10.1016/j.clineuro.2012.12.031

12.

Jena

Price

Baker

, et al. Diffusion tensor imaging: possible implications for radiotherapy treatment planning of patients with high-grade glioma. Clin Oncol 2005; 17(8): 581–590. https://doi.org/10.1016/j.clon.2005.04.012

13.

Petrecca

Guiot

Panet-Raymond

, et al. Failure pattern following complete resection plus radiotherapy and temozolomide is at the resection margin in patients with glioblastoma. J Neuro Oncol 2013; 111(1): 19–23. https://doi.org/10.1007/s11060-012-0983-4

14.

Gerritsen

JKW

Young

Chang

, et al. SUPRAMAX-study: supramaximal resection versus maximal resection for glioblastoma patients: study protocol for an international multicentre prospective cohort study (ENCRAM 2201). BMJ Open 2024; 14(4): e082274. https://doi.org/10.1136/bmjopen-2023-082274

15.

Shah

Mahavadi

, et al. Radical supramaximal resection for newly diagnosed left-sided eloquent glioblastoma: safety and improved survival over gross-total resection. J Neurosurg 2023; 138(1): 62–69. https://doi.org/10.3171/2022.3.JNS212399

16.

Suki

Hess

, et al.

The influence of maximum safe resection of glioblastoma on survival in 1229 patients: can we do better than gross-total resection?

JNS 2016; 124(4): 977–988. https://doi.org/10.3171/2015.5.JNS142087

17.

Lescher

Jurcoane

Veit

, et al. Quantitative T1 and T2 mapping in recurrent glioblastomas under bevacizumab: earlier detection of tumor progression compared to conventional MRI. Neuroradiology 2015; 57(1): 11–20. https://doi.org/10.1007/s00234-014-1445-9

18.

Blystad

Warntjes

JBM

Smedby

, et al. Quantitative MRI using relaxometry in malignant gliomas detects contrast enhancement in peritumoral oedema. Sci Rep 2020; 10(1): 17986. https://doi.org/10.1038/s41598-020-75105-6

19.

Müller

Jurcoane

Kebir

, et al. Quantitative T1‐mapping detects cloudy‐enhancing tumor compartments predicting outcome of patients with glioblastoma. Cancer Med 2017; 6(1): 89–99. https://doi.org/10.1002/cam4.966

20.

Martín-Noguerol

Mohan

Santos-Armentia

, et al. Advanced MRI assessment of non-enhancing peritumoral signal abnormality in brain lesions. Eur J Radiol 2021; 143: 109900. https://doi.org/10.1016/j.ejrad.2021.109900

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.02 MB